Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903 · see citing works

Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host

Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481 · see citing works

Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes

Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., & Goldstein, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534923100 · Cited by 1,427 · see citing works

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089 · see citing works

NF-κB: pivotal mediator or innocent bystander in atherogenesis?

Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · see citing works

Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects

Tripathy, D., Mohanty, P., Dhindsa, S., Syed, T., Ghanim, H., Aljada, A., & Dandona, P. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2882 · Cited by 658 · see citing works

Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice

Ip, E., Farrell, G. C., Robertson, G., Hall, P., Kirsch, R., & Leclercq, I. (2003) · Hepatology · doi:10.1053/jhep.2003.50307 · Cited by 476 · see citing works

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

Gervois, P. P., Fruchart, J., Delerive, P., & Staels, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004045200 · Cited by 457 · see citing works

Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383 · see citing works

Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.

Liao, F., Andalibi, A., deBeer, F. C., et al. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116495 · Cited by 299 · see citing works

Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2.

Sullivan, P. M., Mezdour, H., Quarfordt, S. H., & Maeda, N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2673 · Cited by 254 · cited 5× · see citing works

Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model

Kim, S., Sohn, I., Ahn, J., Lee, K.-H., Lee, Y. S., & Lee, Y. S. (2004) · Gene · doi:10.1016/j.gene.2004.06.015 · Cited by 249 · see citing works

REVIEW: Nonalcoholic steatohepatitis

Ludwig, J., McGill, D. B., & Lindor, K. D. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00450.x · Cited by 247 · see citing works

Multiple Cytokines Stimulate Hepatic Lipid Synthesisin Vivo*

FEINGOLD, K. R., Soued, M., Serio, M., MOSER, A. H., Dinarello, C. A., & Grünfeld, C. (1989) · Endocrinology · doi:10.1210/endo-125-1-267 · Cited by 210 · see citing works

Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression

Vergnes, L., Phan, J., Strauss, M., Tafuri, S. R., & Reue, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306022200 · Cited by 203 · see citing works

Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice

Grainger, D. J., Reckless, J., & McKilligin, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6366 · Cited by 183 · see citing works

Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.

Kuipers, F., Jong, M. C., Lin, Y., Eck, M. V., Havinga, R., Bloks, V. W., Verkade, H. J., Hofker, M. H., Moshage, H. J., van Berkel, T. J. C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119841 · Cited by 167 · see citing works

Atherosclerotic Lesions Grow Through Recruitment and Proliferation of Circulating Monocytes in a Murine Model

Lessner, S. M., Prado, H. L., Waller, E. K., & Galis, Z. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61163-7 · Cited by 166 · see citing works

Analysis of techniques to obtain plasma for measurement of levels of free fatty acids

Zambon, A., Hashimoto, S., & Brunzell, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39687-5 · Cited by 143 · see citing works

Microarray Analysis of Gene Expression Changes in Mouse Liver Induced by Peroxisome Proliferator- Activated Receptor α Agonists

Yamazaki, K., Kuromitsu, J., & Tanaka, I. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6319 · Cited by 106 · see citing works

Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition

Ghesquiere, S. A. I., Gijbels, M. J., Anthonsen, M. W., van Gorp, P. J., van der Made, I., Johansen, B., Hofker, M. H., & de Winther, M. P. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400253-jlr200 · Cited by 82 · see citing works

Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis

Tous, M., Ferr�, N., Camps, J., Riu, F., & Joven, J. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-2997-0 · Cited by 76 · see citing works

Fatty acid binding protein in heart and skeletal muscles of the migratory barnacle goose throughout development

Pelsers, M. M. A. L., Butler, P. J., Bishop, C. M., & Glatz, J. F. C. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.3.r637 · Cited by 51 · see citing works

Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process

Yoshimatsu, M., Terasaki, Y., Sakashita, N., Kiyota, E., Sato, H., van der Laan, L. J. W., & Takeya, M. (2004) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2004.00401.x · Cited by 47 · see citing works

PPAR alpha, fibrates, lipid metabolism and inflammation.

Duval, C., Fruchart, J. C., & Staels, B. (2004) · PubMed · Cited by 43 · see citing works

Doubling Expression of the Low Density Lipoprotein Receptor by Truncation of the 3′-Untranslated Region Sequence Ameliorates Type III Hyperlipoproteinemia in Mice Expressing the Human ApoE2 Isoform

Knouff, C. W., Malloy, S. I., Wilder, J., Altenburg, M. K., & Maeda, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009423200 · Cited by 36 · see citing works

The effect of diet on tumor necrosis factor stimulation of hepatic lipogenesis

Feingold, K. R., Soued, M., Serio, M., Adi, S., Moser, A. H., & Grünfeld, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90030-g · Cited by 35 · see citing works

Fatty Acids and Gene Expression Related to Inflammation

Calder, P. C. (2002) · KARGER eBooks · doi:10.1159/000067510 · Cited by 31 · see citing works

Treatment of nonalcoholic fatty liver disease

Liangpunsakul, S., & Chalasani, N. (2003) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-003-0047-0 · Cited by 25 · see citing works

Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor

Knouff, C. W., Briand, O., Lestavel, S., Barthelemy-Clavey, V., Altenburg, M. K., & Maeda, N. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.03.004 · Cited by 24 · see citing works

Treatment of type III hyperlipoproteinemia with four different treatment regimens

Hoogwerf, B. J., Bantle, J. P., Kuba, K., et al. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90172-2 · Cited by 22 · see citing works

Effect of Dietary Enrichment with n-3 Polyunsaturated Fatty Acids (PUFA) or n-9 PUFA on Arachidonate Metabolism in Vivo and Experimentally Induced Inflammation in Mice

Doshi, M., Watanabe, S., Niimoto, T., et al. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.319 · Cited by 16 · see citing works

Identification of Differentially Regulated Genes in Mildly Hyperlipidemic ApoE3-Leiden Mice by Use of Serial Analysis of Gene Expression

Kreeft, A. J., Moen, C. J. A., Hofker, M. H., Frants, R. R., Vreugdenhil, E., Gijbels, M. J., Havekes, L. M., & Datson, N. A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100265 · Cited by 12 · see citing works

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice

Hinsdale, M. E., Sullivan, P. M., Mezdour, H., & Maeda, N. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200103-jlr200 · Cited by 12 · see citing works

Kupffer Cells Promote Hepatic Steatosis Via Interleukin-1β–Dependent Suppression of Peroxisome Proliferator-Activated Receptor α Activity

Stienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J. E. M., van Rooijen, N., Staels, B., Kersten, S., & Müller, M. (2010) · Hepatology · doi:10.1002/hep.23337 · Cited by 452 · see citing works

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: Hepatology

Staels, B., Rubenstrunk, A., Noel, B., Rigou, G., Delataille, P., Millatt, L. J., Baron, M., Lucas, A., Tailleux, A., Hum, D. W., et al. (2013) · Hepatology · doi:10.1002/hep.26461 · Cited by 414 · see citing works

PPARs, Obesity, and Inflammation

Stienstra, R., Duval, C., Müller, M., & Kersten, S. (2007) · PPAR Research · doi:10.1155/2007/95974 · Cited by 287 · see citing works

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

Ibrahim, S. H., Hirsova, P., Malhi, H., & Gores, G. J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3977-1 · Cited by 218 · see citing works

Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases

Yamashita, S., Masuda, D., & Matsuzawa, Y. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-0823-5 · Cited by 191 · see citing works

Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease

Souza-Mello, V. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1012 · Cited by 182 · see citing works

The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

Pawlak, M., Baugé, E., Bourguet, W., De Bosscher, K., Lalloyer, F., Tailleux, A., Lebherz, C., Lefebvre, P., & Staels, B. (2014) · Hepatology · doi:10.1002/hep.27297 · Cited by 141 · see citing works

Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice

Wouters, K., van Bilsen, M., van Gorp, P. J., Bieghs, V., Lütjohann, D., Kerksiek, A., Staels, B., Hofker, M. H., & Shiri-Sverdlov, R. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.046 · Cited by 109 · see citing works

Deficiency of <i>Cbl-b</i> Gene Enhances Infiltration and Activation of Macrophages in Adipose Tissue and Causes Peripheral Insulin Resistance in Mice

Hirasaka, K., Kohno, S., Goto, J., Furochi, H., Mawatari, K., Harada, N., Hosaka, T., Nakaya, Y., Ishidoh, K., Obata, T., et al. (2007) · Diabetes · doi:10.2337/db06-1768 · Cited by 69 · see citing works

Liver X receptors, lipids and their reproductive secrets in the male

El-Hajjaji, F.-Z., Oumeddour, A., Pommier, A., Ouvrier, A., Viennois, É., Dufour, J., Caira, F., Drevet, J. R., Volle, D. H., Baron, S., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.004 · Cited by 50 · see citing works

Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology

Oumeddour, A., Viennois, É., Caira, F., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.005 · Cited by 9 · see citing works

Recent Advances in Liver X Receptor Biology and Chemistry

Goodwin, B. J., Zuercher, W. J., & Collins, J. L. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608784535075 · Cited by 34 · see citing works

The Pharmacology of LXR

Michael, L., Schkeryantz, J. M., & Burris, T. P. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054553767 · Cited by 65 · see citing works

Therapeutic opportunities for liver X receptor modulators.

Collins, J. L. (2004) · PubMed · Cited by 37 · see citing works